AbbVie Inc. (ABBV)
Exchange: New York Stock Exchange
Currency: USD
Price: 107.54 (Close)
Summary
| 52 Week range | 200d Moving Avg. | Beta |
| 74.67 – 113.10 | 100.22 | 0.60 |
| Dividend | Dividend Yield | Ex-Dividend date |
| 4.75 | 4.42% | 2021-01-14 |
| P/E Ratio | Latest EPS | DGR 3 years |
| 39.54 | 3.68 | 22.62% |
Undervalued
Low
Low Volatility
High
Slow
Dividend Growth
Fast
Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson’s disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.
| Sector: | Industry: | |
| Health Technology | Pharmaceuticals: Major | |
 |
Total ESG Score
35 – 66 percentile
Environment
5 – 7 percentile
Social
23 – 7 percentile
Governance
16 – 7 percentile
Controversy level
3
Peers
– Cardinal Health Inc. (CAH)
– Abbott Laboratories (ABT)
– Becton Dickinson (BDX)
– Medtronic plc (MDT)
– Johnson & Johnson (JNJ)
– West Pharmaceutical Services, Inc (WST)
Dividend Safety Metrics
| Latest EPS | 3.68 | |
| Annual Payout | 4.75 | |
| Payout Ratio | 129.08% | |
| Dividend growth | 25 Years | |
| Dividend Score | 85 | |
| Dividend Coverage Ratio | 0.57 | |
| Altman-Z score | 2.01 | Grey Zone |
Estimated Future Total Return Metrics
| Total return last 5Y | 16.80% | |
| Dividend growth 5Y | 18.50% | |
| Current dividend yield | 4.42% | |
| Average dividend yield last 5Y | 3.88% | |
| Estimated EPS growth next 5Y | 11.20% | |
| Extra return due to over/under valuation | 2.60% | |
| Estimated future return 5Y (CAGR) | 17.70% |
AbbVie Inc. (ABBV) Valuation
AbbVie Inc.’s current dividend yield of 4.42% is 14% above its 5-year average. The 5-year average dividend yield is 3.88% (see red-line in chart). This indicates the stock may be undervalued today.
AbbVie Inc. (ABBV) Performance
The chart below displays the total price return(%) of AbbVie Inc. for different periods:
AbbVie Inc. (ABBV) Total Return
The chart below displays the (CAGR) total return (%) including all dividends paid of AbbVie Inc. for different periods:
Dividend Scorecard
| Dividend Yield (TTM) | Annual Payout | Payout Ratio | Dividend growth |
| 4.42 | 4.75 | 129.08% | 25 Years |
Dividend Growth Summary
| 3 Year Growth Rate (CAGR) | 22.62% |
| 5 Year Growth Rate (CAGR) | 18.50% |
| 10 Year Growth Rate (CAGR) | 0.00% |
Dividend Growth Rates History
| Year | Payout Amount | Annual Payout Growth (YoY) |
|---|---|---|
| 2021 | 2.600 | -% |
| 2020 | 4.720 | 10.3% |
| 2019 | 4.280 | 19.2% |
| 2018 | 3.590 | 40.2% |
| 2017 | 2.560 | 12.3% |
| 2016 | 2.280 | 12.9% |
| 2015 | 2.020 | 21.7% |
| 2014 | 1.660 | 3.8% |
| 2013 | 1.600 | 0.0% |
AbbVie Inc. (ABBV) Dividend Payment History